TNF and Fulminant hepatitis: To examine the anti-TNF-α effect of MA-35 in vivo, we next examined the effect in the LPS/D-galactosamine (D-GalN) induced-fulminant hepatitis mice model, in which TNF-α plays a main pathway in the pathogenic condition16.